Intermed Labs at Mon Health is focused on the medical technology space to help health care entrepreneurs transform innovative medical solutions into viable commercial activities . The ecosystem that has been assembled on the campus of Mon Health in Morgantown is diverse and experienced . The build team extends across multiple practice areas such as engineering , data science , design , marketing and finance . Also , strong relationships have been established with regulatory , intellectual property and consulting firms , which adds a significant depth to project development . Finally , the studio is vertically integrated with a venture capital group and angel investing group to provide follow-on funding once a new company is started .
The benefits of innovation labs explicitly tied to health systems run in all directions as reported in Medical Device Technologies . The system gets early access to new technology , as well as potential financial returns . The startup gets logistical help and a place to try out its new technology ,
The benefits of innovation labs explicitly tied to health systems run in all directions . The system gets early access to new technology , as well as potential financial returns . The startup gets logistical help and a place to try out its new technology , and patients get access to new care models and devices .
and patients get access to new care models and devices .
“ In medicine , there is a difficult process of translation where a product must move from idea to the bench and finally to the patient ,” says David Goldberg , CEO of Mon Health . “ A community system with a strong tradition of patient-centered care , like Mon Health , is an ideal platform to test concepts and helps fulfill our mission to serve the citizens of West Virginia .”
Recently , Intermed Labs was accepted into the Global Startup Studio Network ( GSSN ), a tight-knit group of the world ’ s top venture building studios . GSSN connects innovators from member studios all over the world in places like Dubai , Palo Alto , Paris and Morgantown to increase access to operational processes and human and financial capital .
“ Intermed Labs is using its unique expertise to disrupt a legacy industry and share with health systems across the globe ,” says Nick Zasowski , GSSN director . “ The work they are doing will drive more efficient growth , and we see their studio model as the future standard in medical device innovation .” •
WWW . WVEXECUTIVE . COM WINTER 2021 83